HIF1A and breast cancer: According to reports, the HIF-1α/miR-210 signalling axis regulates mitochondrial free radicals in response to hypoxia in cancer cells by targeting downregulation of ISCU expression, which correlates with poor prognosis in breast cancer and HNSCC [58] and good prognosis in renal cancer [59].